When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Catalyst Pharmaceuticals (CPRX) has filed patent infringement litigation in two U.S. district courts against Jacobus Pharmaceuticals and PantherRx Rare LLC, respectively, related to their marketing of Ruzurgi (amifampridine, 10 mg), an unauthorized generic version of Firdapse (amifampridine) Tablets 10 mg.The FDA approved Firdapse in November 2018 for a rare neuromuscular disorder called Lambert-Eaton myasthenic syndrome.